Compare CSPC Pharmaceutical Group Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
HKD 88,608 Million ()
49.00
NA
0.03%
-0.25
5.72%
2.40
Revenue and Profits:
Net Sales:
3,119 Million
(Quarterly Results - Dec 2016)
Net Profit:
536 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.9%
0%
-26.9%
6 Months
4.2%
0%
4.2%
1 Year
18.67%
0%
18.67%
2 Years
18.13%
0%
18.13%
3 Years
1.05%
0%
1.05%
4 Years
-2.66%
0%
-2.66%
5 Years
-31.09%
0%
-31.09%
CSPC Pharmaceutical Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.96%
EBIT Growth (5y)
19.40%
EBIT to Interest (avg)
29.07
Debt to EBITDA (avg)
2.63
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.36
Tax Ratio
19.81%
Dividend Payout Ratio
78.68%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
18.91%
ROE (avg)
14.36%
Valuation key factors
Factor
Value
P/E Ratio
49
Industry P/E
Price to Book Value
2.87
EV to EBIT
34.49
EV to EBITDA
28.55
EV to Capital Employed
3.60
EV to Sales
7.61
PEG Ratio
2.16
Dividend Yield
0.02%
ROCE (Latest)
10.43%
ROE (Latest)
5.80%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Jun 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY
Dec'16
Dec'15
Change(%)
Net Sales
3,118.70
2,890.80
7.88%
Operating Profit (PBDIT) excl Other Income
764.70
704.30
8.58%
Interest
8.60
13.60
-36.76%
Exceptional Items
0.00
0.00
Consolidate Net Profit
535.70
424.70
26.14%
Operating Profit Margin (Excl OI)
199.70%
189.70%
1.00%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2016 is 7.88% vs 2.64% in Dec 2015
Consolidated Net Profit
YoY Growth in quarter ended Dec 2016 is 26.14% vs 20.79% in Dec 2015
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
28,204.10
31,452.50
-10.33%
Operating Profit (PBDIT) excl Other Income
5,838.80
7,252.70
-19.49%
Interest
41.90
47.40
-11.60%
Exceptional Items
363.90
-113.30
421.18%
Consolidate Net Profit
4,204.00
4,704.30
-10.63%
Operating Profit Margin (Excl OI)
152.80%
184.50%
-3.17%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -10.33% vs -9.50% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -10.63% vs -29.89% in Dec 2024
About CSPC Pharmaceutical Group Ltd. 
CSPC Pharmaceutical Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






